Looking for the latest information on Bioskryb? We've researched comprehensive data, records, and insights about Bioskryb.
Main Features
Explore the main sources for Bioskryb.
History
Stay updated on Bioskryb's newest achievements.
BioSkryb, Inc: The Invention of PTA
Bioskryb webinar : Clonal Evolution of Paediatric Burkitt Lymphoma Through Time and Space
A day in the life of a BioSkryb Researcher
PORTFOLIO SPOTLIGHT: BioSkryb Genomics
AMP 2023: Discover Tumor Heterogeneity with Integrated Single-Cell Genomics and Transcriptomics
Leveraging single-cell WGS to identify CRISPR/Cas9 gene editing on- and off-target events
Resolve cancer heterogeneity with single-cell resolution
Studying Cellular Evolution with PTA
BaseJumper Demo
Leveraging Single-Cell WGS to Identify CRISPR/Cas9 Gene Editing On and Off-Target Events
Gene Editing: Past, Present, and Future
Detailed Analysis
Data is compiled from public records and verified media reports.
Last Updated: October 14, 2026
Final Thoughts
For 2026, Bioskryb remains one of the most talked-about information profiles. Check back for the latest updates.
Disclaimer: Disclaimer: All information is compiled from publicly available data, media reports, and analysis. Actual details may vary.
Summary
Primary Template-directed Amplification or PTA employs controlled reaction parameters to reproducibly recover greater than 95% ... ResolveOME is a unified, single-cell workflow that amplifies both the whole genome and full-length transcriptome and is ... A Revolution in Single Cell Genomics featuring ResolveDNA™ and ResolveOME Primary Template-directed Amplification (PTA) ... Revealing the Story within Every Single Cell. Cells explored. Answers revealed. Watch our rockstar Gail (with a guest appearance by Jon) working on PTA cleanup, checking the concentration of the PTA product ... In this workshop, learn how ResolveOME™, an integrated single-cell genomic and transcriptomic workflow, was used to ... Learn how single-cell whole genome sequencing can be used to identify CRISPR/Cas9 gene editing on- and off-target events. Do you want to accelerate your research efforts to better understand cancer heterogeneity and improve cancer outcomes? Charles Gawad, MD, PhD, Associate Profession at Stanford University, Investigator at the Chan Zuckerberg Biohub, and Accelerate genomic exploration today with the BaseJumper bioinformatics platform. Leveraging Single-Cell WGS to Identify CRISPR/Cas9 Gene Editing On and Off-Target Events Webinar presented by Join Phyll Arrington and Stephanie Scherer, PhD as they discuss the future of gene editing and where single cell genomics and ...